<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="23" left="55" width="517" height="33" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="77" left="138" width="53" height="12" font="1">Sep 12, 2011</text>
<text top="359" left="94" width="332" height="12" font="1">Goat polyclonal IgG, epitope mapping at the C-terminus of LRF of human origin.</text>
<text top="485" left="150" width="31" height="12" font="1">Human</text>
<text top="521" left="178" width="53" height="12" font="2">Western Blot</text>
<text top="134" left="326" width="102" height="12" font="1">fpauli@hudsonalpha.org</text>
<text top="134" left="83" width="61" height="12" font="1">Florencia Pauli</text>
<text top="215" left="121" width="83" height="12" font="1">ZBTB7A_(SC-34508)</text>
<text top="215" left="339" width="33" height="12" font="1">ZBTB7A</text>
<text top="170" left="230" width="25" height="12" font="1">Myers</text>
<text top="255" left="239" width="107" height="12" font="1">Santa Cruz Biotechnology</text>
<text top="485" left="361" width="22" height="12" font="1">Goat </text>
<text top="300" left="395" width="27" height="12" font="1">H2406</text>
<text top="300" left="215" width="37" height="12" font="1">sc-34508</text>
<text top="521" left="395" width="54" height="12" font="2">IP-Mass Spec</text>
<text top="561" left="356" width="43" height="12" font="2">Polyclonal</text>
<text top="413" left="94" width="453" height="12" font="1">Plays a key role in the instruction of early lymphoid progenitors to develop into B lineage by repressing T-cell </text>
<text top="425" left="94" width="164" height="12" font="1">instructive Notch signals (By similarity). </text>
<text top="437" left="94" width="2" height="12" font="1"> </text>
<text top="449" left="94" width="121" height="12" font="1">Entrez gene ID 16969; 62 kDa</text>
<text top="599" left="238" width="177" height="12" font="1">http://www.scbt.com/datasheet-34508-lrf-</text>
<text top="611" left="238" width="80" height="12" font="1">c-18-antibody.html</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="80" left="125" width="95" height="12" font="1">Western blot protocol: </text>
<text top="92" left="125" width="428" height="12" font="1">Whole cell lysate was immunoprecipitated using primary antibody, and the IP fraction was loaded on a </text>
<text top="104" left="125" width="422" height="12" font="1">12% acrylamide gel and separated with a Bio-Rad PROTEAN II xi system. After separation, the samples </text>
<text top="116" left="125" width="422" height="12" font="1">were transferred to a nitrocellulose membrane with an Invitrogen iBlot system.  Blotting with primary </text>
<text top="128" left="125" width="422" height="12" font="1">(same as that used for IP) and secondary HRP-conjugated antibodies was performed on an Invitrogen </text>
<text top="140" left="125" width="414" height="12" font="1">BenchPro 4100 system. Visualization was achieved using SuperSignal West Femto solution (Thermo </text>
<text top="152" left="125" width="47" height="12" font="1">Scientific).  </text>
<text top="164" left="125" width="2" height="12" font="1"> </text>
<text top="176" left="125" width="346" height="12" font="1">Results: Band of expected size visualized, representing strongest signal in the lane.  </text>
<text top="188" left="125" width="2" height="12" font="1"> </text>
<text top="200" left="125" width="427" height="12" font="1">Figure legend: IP-western with sc-34508 in nuclear extract of K562 and whole cell lysate (WCL) of K562, </text>
<text top="212" left="125" width="300" height="12" font="1">GM12878 and HepG2; PM=protein marker. ZBTB7A bands are indicated. </text>
</page>
<page number="3" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="99" left="130" width="144" height="12" font="1">IP followed by mass spectrometry: </text>
<text top="111" left="130" width="419" height="12" font="1">Briefly, K562 whole cell lysates were immunoprecipitated using primary antibody, and the IP fraction </text>
<text top="123" left="130" width="402" height="12" font="1">was loaded on a 12% acrylamide gel and separated with a Bio-Rad PROTEAN II xi system. Gel was </text>
<text top="135" left="130" width="417" height="12" font="1">stained with Coomassie Blue in order to visualize marker bands. Gel fragments corresponding to the </text>
<text top="147" left="130" width="420" height="12" font="1">bands indicated above in the western blot image were excised and sent to the University of Alabama </text>
<text top="159" left="130" width="423" height="12" font="1">at Birmingham Cancer Center Mass Spectrometry/Proteomics Shared Facility. There the samples were </text>
<text top="171" left="130" width="423" height="12" font="1">run on an LTQ XL Linear Ion Trap Mass Spectrometer by LC-ESI-MS/MS. Peptides were identified using </text>
<text top="183" left="130" width="355" height="12" font="1">SEQUEST tandem mass spectra analysis, with probability based matching at p &lt; 0.05.  </text>
<text top="195" left="130" width="2" height="12" font="1"> </text>
<text top="207" left="130" width="268" height="12" font="1">As per ENCODE data standards, all SEQUEST results are attached </text>
<text top="219" left="130" width="399" height="12" font="1">(ENCODE_HAIB_ZBTB7A_sc34508_09122011_MassSpec.pdf), including common contaminants. </text>
<text top="231" left="130" width="205" height="12" font="1">Target protein is listed as hit 48 in ~75 kDa) band.</text>
<text top="695" left="268" width="68" height="12" font="1">Submit by Email</text>
</page>
<page number="4" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="3" size="11" family="Times" color="#000000"/>
	<fontspec id="4" size="10" family="Times" color="#000000"/>
	<fontspec id="5" size="5" family="Times" color="#000000"/>
<text top="72" left="77" width="282" height="16" font="3"><b>Validation 2: Mass Spectrometry Analysis </b></text>
<text top="98" left="77" width="467" height="13" font="4">ENCODE data standards recognizes various methodologies for secondary validation of </text>
<text top="112" left="77" width="467" height="13" font="4">antibodies.  Among  these  methodologies  is  immunoprecipitation  followed  by  mass </text>
<text top="126" left="77" width="467" height="13" font="4">spectrometry analysis. Briefly, K562 whole cell lysates were immunoprecipitated using </text>
<text top="140" left="77" width="467" height="13" font="4">primary  antibody,  and  the  IP  fraction  was  loaded  on  a  12%  acrylamide  gel  and </text>
<text top="154" left="77" width="467" height="13" font="4">separated with a Bio-Rad PROTEAN II xi system. Gel was stained with Coomasie Blue </text>
<text top="167" left="77" width="467" height="13" font="4">in order to visualize marker bands. A gel fragment corresponding to the band indicated </text>
<text top="181" left="77" width="467" height="13" font="4">above in the western blot image was excised and sent to the University of Alabama at </text>
<text top="195" left="77" width="467" height="13" font="4">Birmingham Cancer Center Mass Spectrometry/Proteomics Shared Facility. There the </text>
<text top="209" left="77" width="467" height="13" font="4">sample  was  run  on  an  LTQ  XL  Linear  Ion  Trap  Mass  Spectrometer  with  alternating </text>
<text top="223" left="77" width="467" height="13" font="4">collision-induced  dissociation  and  electron-transfer  dissociation.  Peptides  were </text>
<text top="236" left="77" width="467" height="13" font="4">identified using MASCOT (Matrix Science), with probability based matching at p &lt; 0.05. </text>
<text top="250" left="77" width="467" height="13" font="4">Subsequent  analysis  was  performed  in  Scaffold  (Proteome  Software,  Inc.)  at  0.0% </text>
<text top="264" left="77" width="467" height="13" font="4">protein  FDR  and  0.0%  peptide  FDR.  As  per  ENCODE  data  standards,  all  Scaffold </text>
<text top="278" left="77" width="467" height="13" font="4">results are listed below, including common contaminants. Target protein is highlighted </text>
<text top="292" left="77" width="65" height="13" font="4">in bold font. </text>
<text top="315" left="77" width="4" height="16" font="3"><b> </b></text>
<text top="341" left="90" width="9" height="9" font="5">1. </text>
<text top="341" left="108" width="286" height="9" font="5">Heat shock cognate 71 kDa protein OS=Homo sapiens GN=HSPA8 PE=1 SV=1 </text>
<text top="341" left="414" width="63" height="9" font="5">HSP7C_HUMAN </text>
<text top="355" left="90" width="9" height="9" font="5">2. </text>
<text top="355" left="108" width="285" height="9" font="5">Heat shock 70 kDa protein 1A/1B OS=Homo sapiens GN=HSPA1A PE=1 SV=5 </text>
<text top="355" left="414" width="61" height="9" font="5">HSP71_HUMAN </text>
<text top="369" left="90" width="9" height="9" font="5">3. </text>
<text top="369" left="108" width="283" height="9" font="5">T-complex protein 1 subunit gamma OS=Homo sapiens GN=CCT3 PE=1 SV=4 </text>
<text top="369" left="414" width="58" height="9" font="5">TCPG_HUMAN </text>
<text top="383" left="90" width="9" height="9" font="5">4. </text>
<text top="383" left="108" width="257" height="9" font="5">Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 </text>
<text top="383" left="378" width="56" height="9" font="5">K2C1_HUMAN </text>
<text top="397" left="90" width="9" height="9" font="5">5. </text>
<text top="397" left="108" width="315" height="9" font="5">X-ray repair cross-complementing protein 6 OS=Homo sapiens GN=XRCC6 PE=1 SV=2 </text>
<text top="397" left="450" width="63" height="9" font="5">XRCC6_HUMAN </text>
<text top="410" left="90" width="9" height="9" font="5">6. </text>
<text top="410" left="108" width="432" height="9" font="5">Insulin-like  growth  factor  2  mRNA-binding  protein  1  OS=Homo  sapiens  GN=IGF2BP1  PE=1  SV=2</text>
<text top="424" left="108" width="2" height="9" font="5"> </text>
<text top="424" left="126" width="57" height="9" font="5">IF2B1_HUMAN </text>
<text top="438" left="90" width="9" height="9" font="5">7. </text>
<text top="438" left="108" width="326" height="9" font="5">Heterogeneous nuclear ribonucleoprotein M OS=Homo sapiens GN=HNRNPM PE=1 SV=3 </text>
<text top="438" left="450" width="65" height="9" font="5">HNRPM_HUMAN </text>
<text top="452" left="90" width="9" height="9" font="5">8. </text>
<text top="452" left="108" width="321" height="9" font="5">Probable ATP-dependent RNA helicase DDX5 OS=Homo sapiens GN=DDX5 PE=1 SV=1 </text>
<text top="452" left="450" width="57" height="9" font="5">DDX5_HUMAN </text>
<text top="466" left="90" width="9" height="9" font="5">9. </text>
<text top="466" left="108" width="290" height="9" font="5">Arginyl-tRNA synthetase, cytoplasmic OS=Homo sapiens GN=RARS PE=1 SV=2 </text>
<text top="466" left="414" width="58" height="9" font="5">SYRC_HUMAN </text>
<text top="479" left="90" width="346" height="9" font="5">10.  Eukaryotic translation initiation factor 3 subunit L OS=Homo sapiens GN=EIF3L PE=1 SV=1 </text>
<text top="479" left="450" width="57" height="9" font="5">EIF3L_HUMAN </text>
<text top="493" left="90" width="327" height="9" font="5">11.  Phenylalanyl-tRNA synthetase beta chain OS=Homo sapiens GN=FARSB PE=1 SV=3 </text>
<text top="493" left="450" width="57" height="9" font="5">SYFB_HUMAN </text>
<text top="507" left="90" width="292" height="9" font="5">12.  Stress-70 protein, mitochondrial OS=Homo sapiens GN=HSPA9 PE=1 SV=2 </text>
<text top="507" left="414" width="62" height="9" font="5">GRP75_HUMAN </text>
<text top="521" left="90" width="267" height="9" font="5">13.  Transketolase OS=Homo sapiens GN=TKT PE=1 SV=3 TKT_HUMAN </text>
<text top="535" left="90" width="273" height="9" font="5">14.  Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 </text>
<text top="535" left="378" width="56" height="9" font="5">K1C9_HUMAN </text>
<text top="548" left="90" width="276" height="9" font="5">15.  Fermitin family homolog 3 OS=Homo sapiens GN=FERMT3 PE=1 SV=1 </text>
<text top="548" left="378" width="57" height="9" font="5">URP2_HUMAN </text>
<text top="562" left="90" width="308" height="9" font="5">16.  Heat shock protein HSP 90-beta OS=Homo sapiens GN=HSP90AB1 PE=1 SV=4 </text>
<text top="562" left="414" width="61" height="9" font="5">HS90B_HUMAN </text>
<text top="576" left="90" width="450" height="9" font="5">17.  Insulin-like  growth  factor  2  mRNA-binding  protein  3  OS=Homo  sapiens  GN=IGF2BP3  PE=1  SV=2</text>
<text top="590" left="108" width="2" height="9" font="5"> </text>
<text top="590" left="126" width="57" height="9" font="5">IF2B3_HUMAN </text>
<text top="604" left="90" width="274" height="9" font="5">18.  Lamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1  LMNA_HUMAN </text>
<text top="617" left="90" width="314" height="9" font="5">19.  Nucleolar protein 56 OS=Homo sapiens GN=NOP56 PE=1 SV=4  NOP56_HUMAN </text>
<text top="631" left="90" width="309" height="9" font="5">20.  Nuclear pore complex protein Nup85 OS=Homo sapiens GN=NUP85 PE=1 SV=1 </text>
<text top="631" left="414" width="62" height="9" font="5">NUP85_HUMAN </text>
<text top="645" left="90" width="450" height="9" font="5">21.  Calcium-binding  mitochondrial  carrier  protein  Aralar2  OS=Homo  sapiens  GN=SLC25A13  PE=1  SV=2</text>
<text top="659" left="108" width="2" height="9" font="5"> </text>
<text top="659" left="126" width="59" height="9" font="5">CMC2_HUMAN </text>
<text top="673" left="90" width="119" height="9" font="5">22.  Phosphatidylinositol-binding </text>
<text top="673" left="219" width="28" height="9" font="5">clathrin </text>
<text top="673" left="257" width="36" height="9" font="5">assembly </text>
<text top="673" left="303" width="27" height="9" font="5">protein </text>
<text top="673" left="340" width="40" height="9" font="5">OS=Homo </text>
<text top="673" left="390" width="30" height="9" font="5">sapiens </text>
<text top="673" left="430" width="49" height="9" font="5">GN=PICALM </text>
<text top="673" left="488" width="22" height="9" font="5">PE=1 </text>
<text top="673" left="520" width="20" height="9" font="5">SV=2</text>
<text top="686" left="108" width="2" height="9" font="5"> </text>
<text top="686" left="126" width="59" height="9" font="5">PICAL_HUMAN </text>
<text top="700" left="90" width="384" height="9" font="5">23.  Apoptosis-inducing factor 1, mitochondrial OS=Homo sapiens GN=AIFM1 PE=1 SV=1 AIFM1_HUMAN </text>
</page>
<page number="5" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="6" size="5" family="Times" color="#000000"/>
<text top="72" left="90" width="382" height="9" font="5">24.  Protein arginine N-methyltransferase 5 OS=Homo sapiens GN=PRMT5 PE=1 SV=4  ANM5_HUMAN </text>
<text top="86" left="90" width="348" height="9" font="5">25.  Probable ATP-dependent RNA helicase DDX17 OS=Homo sapiens GN=DDX17 PE=1 SV=1 </text>
<text top="86" left="450" width="62" height="9" font="5">DDX17_HUMAN </text>
<text top="100" left="90" width="348" height="9" font="5">26.  Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6  K1C10_HUMAN </text>
<text top="114" left="90" width="313" height="9" font="5">27.  Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 </text>
<text top="114" left="414" width="56" height="9" font="5">K22E_HUMAN </text>
<text top="127" left="90" width="98" height="9" font="5">28.  Phosphoenolpyruvate </text>
<text top="127" left="197" width="53" height="9" font="5">carboxykinase </text>
<text top="127" left="259" width="25" height="9" font="5">[GTP], </text>
<text top="127" left="294" width="50" height="9" font="5">mitochondrial </text>
<text top="127" left="353" width="40" height="9" font="5">OS=Homo </text>
<text top="127" left="401" width="30" height="9" font="5">sapiens </text>
<text top="127" left="440" width="40" height="9" font="5">GN=PCK2 </text>
<text top="127" left="489" width="22" height="9" font="5">PE=1 </text>
<text top="127" left="520" width="20" height="9" font="5">SV=3</text>
<text top="141" left="108" width="2" height="9" font="5"> </text>
<text top="141" left="126" width="65" height="9" font="5">PCKGM_HUMAN </text>
<text top="155" left="90" width="450" height="9" font="5">29.  Dolichyl-diphosphooligosaccharide--protein  glycosyltransferase  subunit  1  OS=Homo  sapiens  GN=RPN1  PE=1  SV=1</text>
<text top="169" left="108" width="2" height="9" font="5"> </text>
<text top="169" left="126" width="57" height="9" font="5">RPN1_HUMAN </text>
<text top="183" left="90" width="339" height="9" font="5">30.  ATP-binding cassette sub-family E member 1 OS=Homo sapiens GN=ABCE1 PE=1 SV=1 </text>
<text top="183" left="450" width="62" height="9" font="5">ABCE1_HUMAN </text>
<text top="196" left="90" width="270" height="9" font="5">31.  Nucleolar RNA helicase 2 OS=Homo sapiens GN=DDX21 PE=1 SV=5 </text>
<text top="196" left="378" width="62" height="9" font="5">DDX21_HUMAN </text>
<text top="210" left="90" width="315" height="9" font="5">32.  ATP-dependent RNA helicase DDX3X OS=Homo sapiens GN=DDX3X PE=1 SV=3 </text>
<text top="210" left="414" width="63" height="9" font="5">DDX3X_HUMAN </text>
<text top="224" left="90" width="239" height="9" font="5">33.  Elongation factor 2 OS=Homo sapiens GN=EEF2 PE=1 SV=4 </text>
<text top="224" left="342" width="51" height="9" font="5">EF2_HUMAN </text>
<text top="238" left="90" width="279" height="9" font="5">34.  Lamin-B1 OS=Homo sapiens GN=LMNB1 PE=1 SV=2  LMNB1_HUMAN </text>
<text top="252" left="90" width="386" height="9" font="5">35.  Sec1 family domain-containing protein 1 OS=Homo sapiens GN=SCFD1 PE=1 SV=4  SCFD1_HUMAN </text>
<text top="265" left="90" width="422" height="9" font="5">36.  ATPase family AAA domain-containing protein 3A OS=Homo sapiens GN=ATAD3A PE=1 SV=2 ATD3A_HUMAN </text>
<text top="279" left="90" width="348" height="9" font="5">37.  Probable ATP-dependent RNA helicase DDX52 OS=Homo sapiens GN=DDX52 PE=1 SV=3 </text>
<text top="279" left="450" width="62" height="9" font="5">DDX52_HUMAN </text>
<text top="293" left="90" width="273" height="9" font="5">38.  Nuclear RNA export factor 1 OS=Homo sapiens GN=NXF1 PE=1 SV=1 </text>
<text top="293" left="378" width="56" height="9" font="5">NXF1_HUMAN </text>
<text top="307" left="90" width="263" height="9" font="5">39.  RNA-binding protein 39 OS=Homo sapiens GN=RBM39 PE=1 SV=2 </text>
<text top="307" left="378" width="63" height="9" font="5">RBM39_HUMAN </text>
<text top="321" left="90" width="385" height="9" font="5">40.  Signal recognition particle 68 kDa protein OS=Homo sapiens GN=SRP68 PE=1 SV=2 SRP68_HUMAN </text>
<text top="334" left="90" width="383" height="9" font="5">41.  Aspartyl-tRNA synthetase, mitochondrial OS=Homo sapiens GN=DARS2 PE=1 SV=1  SYDM_HUMAN </text>
<text top="348" left="90" width="296" height="9" font="5">42.  WD repeat-containing protein 46 OS=Homo sapiens GN=WDR46 PE=1 SV=2 </text>
<text top="348" left="414" width="64" height="9" font="5">WDR46_HUMAN </text>
<text top="362" left="90" width="348" height="9" font="5">43.  Pumilio domain-containing protein KIAA0020 OS=Homo sapiens GN=KIAA0020 PE=1 SV=3 </text>
<text top="362" left="450" width="59" height="9" font="5">K0020_HUMAN </text>
<text top="376" left="90" width="329" height="9" font="5">44.  Leucine-rich repeat-containing protein 47 OS=Homo sapiens GN=LRRC47 PE=1 SV=1 </text>
<text top="376" left="450" width="61" height="9" font="5">LRC47_HUMAN </text>
<text top="390" left="90" width="452" height="9" font="5">45.  Dihydrolipoyllysine-residue  acetyltransferase  component  of  pyruvate  dehydrogenase  complex,  mitochondrial  OS=Homo </text>
<text top="403" left="108" width="113" height="9" font="5">sapiens GN=DLAT PE=1 SV=3 </text>
<text top="403" left="234" width="58" height="9" font="5">ODP2_HUMAN </text>
<text top="417" left="90" width="276" height="9" font="5">46.  Syntaxin-binding protein 2 OS=Homo sapiens GN=STXBP2 PE=1 SV=1 </text>
<text top="417" left="378" width="61" height="9" font="5">STXB2_HUMAN </text>
<text top="431" left="90" width="302" height="9" font="5">47.  E3 ubiquitin/ISG15 ligase TRIM25 OS=Homo sapiens GN=TRIM25 PE=1 SV=1 </text>
<text top="431" left="414" width="58" height="9" font="5">TRI25_HUMAN </text>
<text top="445" left="90" width="450" height="9" font="6"><b>48.  Zinc  finger  and  BTB  domain-containing  protein  7A  OS=Homo  sapiens  GN=ZBTB7A  PE=1  SV=1</b></text>
<text top="459" left="108" width="2" height="9" font="6"><b> </b></text>
<text top="459" left="126" width="62" height="9" font="6"><b>ZBT7A_HUMAN </b></text>
<text top="482" left="90" width="3" height="14" font="4">	 Â </text>
</page>
</pdf2xml>
